["{\n\"step_by_step_thinking\": \"There is no relevant information provided about circRNAs or RNase R in the given documents. The papers discuss topics such as ovine lactoferrin, neuroleptic malignant syndrome, the negligible systemic availability of retinoids, generation of monoclonal antibodies specific for b-pathway ganglio-series gangliosides, and photosensitizers for tumor therapy. Therefore, it is not possible to determine whether circRNAs are susceptible to degradation by RNase R based on this information.\",\n\"answer_choice\": \"B: no\"\n}"]